Active ingredient
Deferoxamine
9 finished FDA listings contain Deferoxamine as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- DEFEROXAMINE MESYLATE
- Dosage forms
- Injection, Powder, For Solution, Injection, Powder, Lyophilized, For Solution
- Routes
- Intramuscular, Intravenous, Subcutaneous
- Manufacturers / labelers
- 6
- Strengths listed
- 2 g/1 · 500 mg/1 · 500 mg/5ml · 95 mg/ml
- Brand names in FDA listings
- Deferoxamine, Desferal
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 3131
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 016267 | MITEM PHARMA | 1968-04-01 | 2 |
| ANDA 076019 | HOSPIRA | 2004-03-17 | 1 |
| ANDA 078718 | FRESENIUS KABI USA | 2009-09-15 | 2 |
| ANDA 207384 | GLAND | 2017-09-29 | 4 |
Official labeling on DailyMed
- DEFEROXAMINE (DEFEROXAMINE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] · version 9 · 2026-07-03
- DEFEROXAMINE MESYLATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GLAND PHARMA LIMITED] · version 6 · 2026-06-02
- DEFEROXAMINE MESYLATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APOTEX CORP.] · version 7 · 2026-06-01
- DEFEROXAMINE MESYLATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] · version 27 · 2026-04-27
- DESFERAL (DEFEROXAMINE MESYLATE) INJECTION, POWDER, FOR SOLUTION [MITEM PHARMA] · version 1 · 2025-11-26
- DESFERAL (DEFEROXAMINE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] · version 20 · 2025-06-18
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.